GGrantIndex
← Search

Pharmacy Shared Core

$7,439P30FY2018CANIH

Mayo Clinic Rochester, Rochester MN

Investigators

Linked publications, trials & patents

Trial NCT06508463Trial NCT06387979Trial NCT06381154Trial NCT06353191Trial NCT06315595Trial NCT06271291Trial NCT06238648Trial NCT06207188Trial NCT06160206Trial NCT06115772Trial NCT06078709Trial NCT06075524Trial NCT06073951Trial NCT06058663Trial NCT05917145Trial NCT05910801Trial NCT05720624Trial NCT05717153Trial NCT05704283Trial NCT05703399Trial NCT05674123Trial NCT05653661Trial NCT05640765Trial NCT05612100Trial NCT05591092Trial NCT05584449Trial NCT05575440Trial NCT05560009Trial NCT05557877Trial NCT05556525Trial NCT05549661Trial NCT05547386Trial NCT05547347Trial NCT05541016Trial NCT05530759Trial NCT05526417Trial NCT05523154Trial NCT05518903Trial NCT05512767Trial NCT05507879Trial NCT05507541Trial NCT05497804Trial NCT05465954Trial NCT05465941Trial NCT05447923Trial NCT05447910Trial NCT05443971Trial NCT05438563Trial NCT05417867Trial NCT05416983Trial NCT05412953Trial NCT05411523Trial NCT05411497Trial NCT05410977Trial NCT05407038Trial NCT05407025Trial NCT05403580Trial NCT05399004Trial NCT05393713Trial NCT05392946Trial NCT05388877Trial NCT05388851Trial NCT05388058Trial NCT05388006Trial NCT05356897Trial NCT05294367Trial NCT05288062Trial NCT05269381Trial NCT05246670Trial NCT05232851Trial NCT05224271Trial NCT05222620Trial NCT05212428Trial NCT05199285Trial NCT05194293Trial NCT05176223Trial NCT05168163Trial NCT05130060Trial NCT05112627Trial NCT05112614Trial NCT05111314Trial NCT05077735Trial NCT05075980Trial NCT05053100Trial NCT05045066Trial NCT05033288Trial NCT05030298Trial NCT05018208Trial NCT05005182Trial NCT04999826Trial NCT04975516Trial NCT04967196Trial NCT04926948Trial NCT04925817Trial NCT04917744Trial NCT04906369Trial NCT04897009Trial NCT04895735Trial NCT04892277Trial NCT04892264

Abstract

1. The Mayo Clinic Cancer Center Pharmacy Shared Resource (PSR) provides comprehensive pharmacy services in support of approximately 350 clinical trials with ongoing patient treatment at Mayo Clinic Rochester (MCR), Mayo Clinic Florida (MCF) and Mayo Clinic Arizona (MCA). 2. The PSR provides pharmacy services exclusively to Mayo Clinic Cancer Center (MCCC) members supporting the Clinical Research Programs of the MCCC. 3. The services of the PSR are essential for protocol development, protocol initiation, and patient treatment on clinical trials. Services include drug procurement, drug storage, and drug accountability of investigational agents assigned to the clinical trials. The PSR is responsible for the preparation and dispensing of cytotoxic chemotherapy, growth factors, immunomodulatory agents, antiemetics, and supportive care medication. The PSR assists the Clinical Protocol Data Management or the Cancer Clinical Research Office Cancer (CPDM/CCRO) previously known as the Clinical Research Office (CCRO), in protocol development by providing review of key sections of each protocol in development including the treatment section, dose modification section, and the drug monograph section. The PSR currently is working on approximately 100 protocols in development. The PSR staff have special expertise with both investigational and commercially available cancer therapeutic agents ensuring a uniformly high standard of safe and accurate treatment for all Mayo Clinic cancer patients. 4. The PSR director has over 39 years of experience in Pharmacy, focused on Hematology and Medical Oncology with past training and experience from the US Public Health Service. 5. For the current grant year approximately 100 MCCC members from 8 programs used the PSR services. 6. The implementation of policies and procedures consistent with guidelines from the American Society of Health Systems Pharmacy, State Boards of Pharmacy, and Joint Commission on Accreditation of Healthcare Organizations ensures regulatory compliance and provides a uniform level of safe, high quality pharmaceutical care to all Mayo Clinic Cancer Center patients receiving chemotherapy.

View original record on NIH RePORTER →